Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
QURE | F | uniQure N.V. | 0.00 | |
BLRX | F | BioLineRx Ltd. | -1.03 | |
AUPH | F | Aurinia Pharmaceuticals Inc | 1.23 | |
MEIP | F | MEI Pharma, Inc. | 0.32 | |
GLPG | F | Galapagos NV | -0.77 | |
ALNY | F | Alnylam Pharmaceuticals, Inc. | 1.48 | |
AMPE | F | Ampio Pharmaceuticals, Inc. | 0.00 | |
FGEN | F | FibroGen, Inc | 0.49 | |
AGRX | F | Agile Therapeutics, Inc. | -1.25 | |
TCON | F | TRACON Pharmaceuticals, Inc. | -1.12 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Related Stock Lists:
Biopharmaceutical
Autoimmune Disease
Life Sciences
Medicine
Biotechnology
Cancer
Drugs
Acute Intermittent Porphyria
Clinical Trial
Hemophilia
Inflammation
Inflammatory Bowel Disease
Kidney Disease
Treatment Of Hemophilia
Abdominal Pain
Acid
Acute Myeloid Leukemia
Adeno Associated Virus
Age Related Macular Degeneration
Alcohol
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
GERM | F | ETFMG Treatments Testing and Advancements ETF | 6.36 | |
GNOM | F | Global X Genomics & Biotechnology ETF | 3.71 | |
BTEC | D | Principal Healthcare Innovators Index ETF | 3.46 | |
FBT | D | First Trust Amex Biotech Index Fund | 3.3 | |
BBP | D | BioShares Biotechnology Products Fund | 2.79 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Medical Devices
Related Stock Lists:
Biopharmaceutical
Autoimmune Disease
Life Sciences
Medicine
Biotechnology
Cancer
Drugs
Acute Intermittent Porphyria
Clinical Trial
Hemophilia
Inflammation
Inflammatory Bowel Disease
Kidney Disease
Treatment Of Hemophilia
Abdominal Pain
Acid
Acute Myeloid Leukemia
Adeno Associated Virus
Age Related Macular Degeneration
Alcohol
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles